PT - JOURNAL ARTICLE AU - Anusha Yeshokumar AU - Eliza Gordon-Lipkin AU - Ana Arenivas AU - Mark Rosenfeld AU - Kristina Patterson AU - Raia Blum AU - Brenda Banwell AU - Arun Venkatesan AU - Eric Lancaster AU - Jessica Panzer AU - John Probasco TI - Younger Age at Onset Is Associated With Worse Long-term Behavioral Outcomes in Anti-NMDA Receptor Encephalitis AID - 10.1212/NXI.0000000000200013 DP - 2022 Sep 01 TA - Neurology - Neuroimmunology Neuroinflammation PG - e200013 VI - 9 IP - 5 4099 - http://nn.neurology.org/content/9/5/e200013.short 4100 - http://nn.neurology.org/content/9/5/e200013.full SO - Neurol Neuroimmunol Neuroinflamm2022 Sep 01; 9 AB - Background and Objectives Anti-NMDA receptor encephalitis (anti-NMDARE) is one of the most common causes of encephalitis. It typically presents in adolescence and young adulthood, but little is known about its potential long-term consequences across the lifespan. Adaptive behavior describes an individual's ability to respond and adapt to environmental demands and unanticipated changes in daily routines. In this study, we evaluate the relationship between features from clinical presentation, including age, and long-term adaptive behavior in participants with anti-NMDARE.Methods Cross-sectional informant-reported data were collected between 2017 and 2019 from 41 individuals/caregivers of individuals with anti-NMDARE treated at 3 major academic hospitals. Neurologic disability was assessed by record review using the modified Rankin Scale (mRS). Functional outcomes were assessed using the validated Adaptive Behavior Assessment System, Third Edition (ABAS-3).Results The mean age at the time of study enrollment was 23.4 years (SD 17.0 years), and the mean time from symptom onset to study enrollment was 4.0 years. Seventeen participants were aged <12 years at symptom onset, 19 participants were aged 12–30 years, and 5 participants were aged >30 years. Mean ABAS-3 scores at study enrollment for all participants were in the average range (mean general adaptive composite standard score 92.5, SD 18.7). Individuals aged <12 years at symptom onset had lower mean ABAS-3 scores and were in the below average range compared with those aged 12–30 years at symptom onset, whose mean scores were in the average range (87 vs 99, p < 0.05). Similar differences were seen in 3 of the individual subscales (functional academics, health and safety, and self-care). There were no significant differences in mRS scores between age groups (p > 0.05).Discussion Although anti-NMDARE is associated with an overall favorable outcome, younger age at onset associates with worse long-term adaptive behavior despite no differences in neurologic disability. These findings suggest that the disease may have distinct consequences on the early developing brain. Future studies should evaluate behavioral recovery and quality of life after anti-NMDARE and identify additional factors associated with differential recovery.ABAS-3=Adaptive Behavior Assessment System, Third Edition; anti-NMDARE=anti-NMDA receptor encephalitis; GAC=general adaptive composite; ICU=intensive care unit; mRS=modified Rankin Scale